National News Politics

Bharat Biotech delivered Covaxin to 30 cities in 1 month; aims WHO approval, US trial

Bharat Biotech is a Hyderabad-based biotechnology company. Its Covid-19 vaccine, Covaxin, is currently being used for inoculation in India.

Covaxin, India’s indigenous Covid-19 vaccine, has reached 30 cities in the past 30 days, said the vaccine manufacturer Bharat Biotech in a statement on Tuesday. Among 30 cities that have received the Covaxin doses include Delhi, Kolkata, Mumbai, Chennai, Bengaluru, Kochi and Amritsar.

Covaxin is one of the three vaccines that the DGCI has cleared for emergency use in India. The two others are Covishield and Sputnik V. While Covishield is the local version of Oxford-AstraZeneca COVID-19 vaccine and being manufactured by Pune-based Serum Institute of India, Sputnik V is a Russian drug.

“COVAXIN reaches 30 cities within 30 day. All our employees are committed, working 24×7 through lockdowns for the country’s immunisation – pls send your prayers to their families, some are still quarantined and off work (sic),” Bharat Biotech Co-founder and joint MD Suchitra Ella said in a twee

Covaxin, India’s indigenous Covid-19 vaccine, has reached 30 cities in the past 30 days, said the vaccine manufacturer Bharat Biotech in a statement on Tuesday. Among 30 cities that have received the Covaxin doses include Delhi, Kolkata, Mumbai, Chennai, Bengaluru, Kochi and Amritsar.

Covaxin is one of the three vaccines that the DGCI has cleared for emergency use in India. The two others are Covishield and Sputnik V. While Covishield is the local version of Oxford-AstraZeneca COVID-19 vaccine and being manufactured by Pune-based Serum Institute of India, Sputnik V is a Russian drug.

“COVAXIN reaches 30 cities within 30 day. All our employees are committed, working 24×7 through lockdowns for the country’s immunisation – pls send your prayers to their families, some are still quarantined and off work (sic),” Bharat Biotech Co-founder and joint MD Suchitra Ella said in a twee

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!